Safety perspectives on presently considered drugs for the treatment of COVID-19.
Sophie L. Penmana*, Robyn T. Kiya*, Rebecca L. Jensena*, Christopher Beoku-Bettsb, Ana Alfirevica, David Backa, Saye H. Khooa, Andrew Owena, Munir Pirmohameda, B. Kevin Parka, Xiaoli Menga#, Christopher E. Goldringa#, Amy E. Chadwicka#
a MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, L69 3GE, UK
b School of Medicine, University of Liverpool, L69 3GE, UK